Retatrutide

Triple GIP/GLP-1/Glucagon Receptor Agonist — Analytical Reference Standard

---

Why Sterile Labs

• Third-party tested, COA on every batch
• Reference-grade — made for research, not diverted retail product
• Sealed vials, handled under controlled conditions
• Same shelf as tirzepatide and semaglutide, so you can compare all three

---

What Is Retatrutide?

Retatrutide is a lab-made peptide that works on three hormone pathways at once — GIP, GLP-1, and glucagon — instead of just one or two. That third pathway, glucagon, is the key difference from tirzepatide: it adds a direct effect on the liver and how much energy the body burns, on top of the insulin and appetite effects. That's why retatrutide has shown some of the biggest weight and fat-loss results of any compound in this class, in preclinical research.

In research models, it's linked to:

• More insulin released when blood sugar is high
• More fat burned in the liver, and higher overall energy use
• Reduced appetite and food intake
• Bigger weight and fat loss than dual- or single-pathway compounds

Like tirzepatide, it's built to stay stable in the body for several days, supporting once-weekly dosing in research protocols.

Sold strictly as an analytical reference material for in vitro research by qualified professionals. Not a pharmaceutical product, supplement, or substance for human or animal use.

---

Where It Shows Up in Research

• Triple- vs. dual- vs. single-pathway comparison studies
• Liver fat research
• Energy expenditure studies
• Fat cell and weight-loss research

---